Fig. 5

Validation of the prognostic value of PCDH17 in three independent AML patient cohorts. a, b Kaplan–Meier analysis of overall survival (OS) in two CN-AML cohorts: GSE12417 cohort 1 (n = 79) (a) and GSE12417 cohort 2 (n = 163) (b). c, d Kaplan–Meier estimate for OS of the Chinese cohort in the whole (c) as well as in the CN-AML (d) patients. Patients were separated into high and low PCDH17 group based on the median expression levels of PCDH17